Meta-analysis of randomized phase II trials to inform subsequent phase III decisions

Treatment-related mortality with aflibercept in cancer patients: a meta-analysis

(2014) Wei-Xiang Qi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis

(2014) Yan Li et al.   Journal of Clinical Hypertension

Predicting clinical trial results based on announcements of interim analyses

(2014) Kristine R Broglio et al.   Trials

Telaprevir Versus Boceprevir in Chronic Hepatitis C: A Meta-Analysis of Data From Phase II and III Trials

(2013) Mugdha Sitole et al.   CLINICAL THERAPEUTICS

Individual participant data meta-analyses should not ignore clustering

(2013) Ghada Abo-Zaid et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews

(2012) Rebecca M Turner et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma

(2011) Jing Hu et al.   Journal of Hematology & Oncology

World Health Organization definition of myocardial infarction: 2008-09 revision

(2010) S. Mendis et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data

(2010) Theo Stijnen et al.   STATISTICS IN MEDICINE

Undue reliance on I 2 in assessing heterogeneity may mislead

(2008) Gerta Rücker et al.   BMC Medical Research Methodology

A re-evaluation of random-effects meta-analysis

(2008) Julian P. T. Higgins et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY

The binomial distribution of meta-analysis was preferred to model within-study variability

(2007) Taye H. Hamza et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY